D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy. - Wikidata - wikimedia - TriplyDB

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

http://www.wikidata.org/entity/Q37373075

about

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.

P2860

Q54966594-64C8E70C-7169-41D0-A1D0-A5373270A919

P2860

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

http://www.wikidata.org/entity/Q37373075

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@en

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@nl

type

label

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@en

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@nl

prefLabel

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@en

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@nl

P1433

Q37373075-90F1B14E-DC1E-4B07-A7A4-43019D3F9556

P1476

Q37373075-F7A9B868-9560-4212-BF2E-3D4633C6E406

P2093

Q37373075-0D6D9D60-565C-424D-8254-7A0DDDAC3421

Q37373075-42B2760C-85D4-445E-8772-31F8AB73DF42

Q37373075-5444FFA9-E659-4592-BD9E-4D9ECE6FE0F2

Q37373075-555DC62A-1D9F-40F9-8134-485E7428D6E6

Q37373075-66B82E55-EE91-42A3-AC36-638105E5C6A9

Q37373075-67D37A79-23F9-407B-B841-EC5F378CF30C

Q37373075-710E153F-0033-4E72-8479-850232F91FE8

Q37373075-75DCDC28-8501-45F7-AD86-12FC28E7F1E1

Q37373075-8B3E5EA8-5B19-4499-BCE9-016B104A0226

Q37373075-8EE679C6-B343-4B73-AD1E-A35CD79806FD

P2860

Q37373075-125C7F3E-8E30-4A4B-93DC-67C87F72F760

Q37373075-288930A4-A30A-43C5-A2DE-915E07C3890F

Q37373075-2EAE2B9A-AC84-4CFB-AFFA-5DACACE90324

Q37373075-42150D05-4AA1-401A-89A7-FCE92598B2BE

Q37373075-45740533-AE63-470D-BF71-F2A89BEEFF65

Q37373075-4A62DB61-2BE6-471E-92D9-5C05D4012ACE

Q37373075-4BB16F1F-B112-47C0-8F9F-D78F28F1E95F

Q37373075-71CAC626-32C0-429E-8619-C94EE5A694D7

Q37373075-7ABB638F-A5F4-4E86-973B-3E4D81631427

Q37373075-98FD051F-2101-47FC-8617-D14347994CB8

P304

Q37373075-88CC457F-8383-47EF-A1A7-CF40C8AD2F1B

P31

Q37373075-B73FA744-B888-4DB7-A093-AEAD41F75EB2

P356

Q37373075-970F2E67-2198-417F-81BC-1EC49804B43B

P407

Q37373075-117DAE22-D81A-49F7-83FD-4ECC5FEC6104

P433

Q37373075-6879D1EF-5CDC-453E-87DC-07EC34C3CB26

P478

Q37373075-B1EA001E-5661-4F10-A7B5-0F049FEC5927

P577

Q37373075-891364D6-376A-4ABB-8245-9A7054F3675B

P698

Q37373075-738C5809-B06F-4A5A-80DE-5DD5ACAAD464

P921

Q37373075-72F4E7D5-4EB2-4408-AEB0-3AEA60A1B8F7

P932

Q37373075-5E330A8A-6270-417F-A330-5481FA6CF687

P356

P1433

Cancer Medicine

P1476

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

@en

P2093

Bin Xiong

http://www.w3.org/2001/XMLSchema#string

Conghua Xie

http://www.w3.org/2001/XMLSchema#string

Fuxiang Zhou

http://www.w3.org/2001/XMLSchema#string

Jin Peng

http://www.w3.org/2001/XMLSchema#string

Jing Dai

http://www.w3.org/2001/XMLSchema#string

Jun Gong

http://www.w3.org/2001/XMLSchema#string

Yahua Zhong

http://www.w3.org/2001/XMLSchema#string

Yue'e Qin

http://www.w3.org/2001/XMLSchema#string

Yuehua Wei

http://www.w3.org/2001/XMLSchema#string

Yunfeng Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials

Global cancer statistics, 2012

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine.

Capecitabine as adjuvant treatment for stage III colon cancer.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.

Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.

P304

2773-2780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.873

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27666138

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5083730

http://www.w3.org/2001/XMLSchema#string